NCT02858323View on ClinicalTrials.gov

Complement (C1q) Binding to HLA Antibodies in a Solid-phase Immunoassay and Clinical Effect on Platelet Transfusion

CompletedOBSERVATIONAL
Enrollment

68

Participants

Timeline

Start Date

July 27, 2016

Primary Completion Date

June 20, 2017

Study Completion Date

June 20, 2017

Conditions
ThrombocytopeniaPlatelet Transfusion Refractoriness
Trial Locations (1)

20892

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
lead

National Institutes of Health Clinical Center (CC)

NIH

NCT02858323 - Complement (C1q) Binding to HLA Antibodies in a Solid-phase Immunoassay and Clinical Effect on Platelet Transfusion | Biotech Hunter | Biotech Hunter